福建平潭综合实验区2013—2015年甲状腺癌发病调查分析

doi:10.11904/j.issn.1002-3070.2020.03.001

Abstract

Abstract: Objective The Objectives of this study were to investigate whether the incidence of thyroid cancer is high in Pingtan comprehensive experimental area,and analyze its incidence characteristics.Methods Thyroid cancer cases with the onset date from 2013 to 2015 in Pingtan were extacted from The Fujian Cancer Incidence Reporting.The basic information and diagnostic information were verified by examining the medical records of the hospital,and non-registered cases were excluded from follow-up.The crude incidence,standard rate and cumulative rate were calculated;the incidence of thyroid cancer in different genders and ages were analyzed;the composition of different pathological types and tumors of different sizes were compared.The standardization rate of China′s population was calculated according to the standard population composition of China in 2000 and the standardization rate of the world population was calculated according to the world population composition of Segi′s.Results From 2013 to 2015,there were 881 new cases of thyroid cancer in Pingtan comprehensive experimental area;They were 205 male and 676 female.The crude incidence of thyroid cancer was 69.30/100 000 and the age-standardized rate was 65.27/100 000 by Chinese standard population;the crude incidence and age-standardized rate of males were 31.78/100 000 and 29.87/100 000,respectively;107.95/100 000 and 101.19/100 000 for female;the incidence of females was 3.18 times than that of males.The median age of onset in men and women was 46 and 47 years old,respectively.Males reached the peak of incidence in the 40-age group,and females form two peaks in the 45-age group and the 55-age group.Papillary carcinoma,follicular carcinoma,medullary carcinoma and others pathological types accounted for 96.52%,1.80%,0.60% and 1.08%,respectively.Microcarcinomas with the largest diameter ≤10 mm accounted for 77.29%.Conclusion The incidence of thyroid cancer in Pingtan comprehensive experimental area is higher than the average levels of Fujian province and the nation.Papillary carcinoma is the main type,and the proportion of microcarcinoma is relatively high.

Key words: Thyroid cancer, Incidence, Pingtan comprehensive experimental area

CLC Number:

R736.1

ZHOU Yan,GAO Rensheng,YAO Xiyu,MA Jingyu,LIN Yongtian,XIANG Zhisheng,JIANG Huijuan. Investigation and analysis of thyroid cancer incidence in Pingtan comprehensive experimental area of Fujian province,2013—2015[J]. Journal of Practical Oncology, 2020, 34(3): 193-197.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2020.03.001

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2020/V34/I3/193

References

1 Global Burden of Disease Cancer Collaboration,Fitzmaurice C,Akinyemiju TF,et al.Global,regional,and national cancer incidence,mortality,years of life lost,years lived with disability,and disability-adjusted life-years for 29 cancer groups,1990 to 2016:a systematic analysis for the Global Burden of Disease Study[J].JAMA Oncol,2018,4(11):1553-1568.
2 中国癌症中心.中国肿瘤登记工作指导手册(2016)[M].北京:人民卫生出版社,2016:59-75.
3 周衍,肖景榕,江惠娟,等.2012年福建省肿瘤登记地区恶性肿瘤发病和死亡分析[J].实用肿瘤学杂志,2016,30(4):304-308.
4 陈万青,孙可欣,郑荣寿,等.2014年中国分地区恶性肿瘤发病和死亡分析[J].中国肿瘤,2018,27(1):1-14.
5 冯莉莉,杨琛,孙乔,等.2010—2014年上海市浦东新区甲状腺癌发病情况分析[J].上海预防医学,2018,30(7):574-578.
6 杨金华.浙江省嘉善县1987—2016 年甲状腺癌的发病趋势及病理分析[J].中国肿瘤,2017,26(10):769-773.
7 Derwahl M,Nicula D.Estrogen and its role in thyroid cancer[J].Endocr Relat Cancer,2014,21(5):273-283.
8 周峰,吴春晓,郑莹,等.1981—2010年上海市市区甲状腺癌的发病趋势[J].环境与职业医学,2015,32(11):997-1002.
9 Ahn HS,Kim HJ,Welch HG.Korea′s thyroid-cancer “epidemic”-screening and overdiagnosis[J].N Engl J Med,2014,371(19):1765-1767.
10 Davies L,Welch HG.Current thyroid cancer trends in the United States[J].JAMA　Otolaryngol　Head Neck Surg,2014,140(4):317-322.
11 Esserman LJ,Thompson IM,Reid B,et al.Addressing overdiagnosis and overtreatment in cancer:a prescription for change[J].Lancet Oncol,2014,15(6):234-242.
12 La Vecchia C,Malvezzi M,Bosetti C,et al.Thyroid cancer mortality andincidence:a global overview[J].Int J Cancer,2015,136(9):2187-2195.
13 James BC,Aschebrook-Kilfoy B,White MG,et al.Quality of life in thyroid cancer-assessment of physician perceptions[J].J Surg Res,2018,6(226):94-99.
14 US Preventive Services Task Force,Bibbins-Domingo K,Grossman DC,et al.Screening for thyroid cancer:US Preventive Services Task Force Recommendation Statement[J].JAMA,2017,317(18):1882-1887.
15 Haugen BR,Alexander EK,Bible KC,et al.2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:The american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J].Thyroid,2016,26(1):1-133.

[1]	SUN Kun, WANG Chong, SHEN Chengfeng, ZHANG Shuang, ZHANG Hui, SONG Guide, WANG Zhuo, WANG Dezheng. Prevalent analysis of malignant tumors in Tianjin,2015 [J]. Journal of Practical Oncology, 2020, 34(2): 114-119.
[2]	LIU Guangxia, ZHAO Lianchun, CHEN Fang, JIA Qian, GAO Wei, HOU Zhan, LU Yamin. Effect and mechanism of ZCCHC12 on malignant transformation of thyroid cells [J]. Journal of Practical Oncology, 2020, 34(2): 133-138.
[3]	WU Dan, WANG Lu, WANG Xinghua, CUI Yali. Inhibitory effect and mechanism of ¹³¹I combined with apatinib on refractory thyroid cancer cells [J]. Journal of Practical Oncology, 2020, 34(2): 139-143.
[4]	ZHOU Jiachen, ZHENG Rongshou, ZHUANG Guihua, ZHANG Siwei, ZENG Hongmei, CHEN Ru, WANG Shaoming, SUN Kexin, ZOU Xiaonong, WEI Wenqiang, HE Jie. Analysis on the trend of gastric cancer incidence and age change in cancer registration regions of China,2000 to 2015 [J]. Journal of Practical Oncology, 2020, 34(1): 1-5.
[5]	DAI Dan, JIA Shangchun, CHEN Yeji, HE Qin, ZHA Zhenqiu, LIU Zhirong. Incidence and death of gastric cancer in Anhui cancer registries,2015 [J]. Journal of Practical Oncology, 2020, 34(1): 6-10.
[6]	ZHANG Maoxiang,SUN Huixin,SONG Bingbing. Analysis of the incidence and mortality of malignant tumors in Daoli District,Harbin,2008—2012 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 261-265.
[7]	LI Cheng, LAN Li, YANG Chao, ZHANG Tingting, WANG Rui, LIN Lin, TIAN Wenjing. Analysis of the incidence and mortality of malignant tumors in Harbin from 2015 to 2017 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 62-66.
[8]	ZHU Xiaoyun, ZHANG Yaning, LIN Fei, MA Biping. Analysis of lung cancer incidence and mortality in Jinshan District of Shanghai from 2002 to 2013 [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 437-441.
[9]	KONG Fanwei, ZHAO Changjiu. The change of peripheral blood cells after iodine 131 treatment in differentiation thyroid cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 476-479.
[10]	ZHOU Yan,XIAO Jingrong,JIANG Huijuan,LIN Yongtian,MA Jingyu. Analysis of cancer incidence and mortality in Fujian cancer registration system in 2012 [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(4): 304-308.
[11]	CHENG Wei,ZHAO Hua. Study on rhTSH-aided radioiodine treatment with ¹³¹I therapy in children and adolescents with differentiated thyroid cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(4): 309-313.
[12]	SUN Ji, MIAO Susheng, PEI Rong, MAO Xionghui. Research of RET in cancer:Current and future [J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(5): 467-470.
[13]	YAO Songyuan,WU Yongmei. The significances tumor abnormal protein detection for diagnosis and prediction of prognosis in gastrointestinal tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(2): 122-126.
[14]	CHEN Wangyang,SONG Bingbing,YANG Fengjuan,SUN Huixin,TAN Xiuzhi,FU Meiqian. Analysis on the cancer incidence and death based on cancer registry of Shangzhi town in 2009 year [J]. PRACTICAL ONCOLOGY JOURNAL, 2012, 26(6): 506-510.
[15]	CHEN Wanqing,ZHENG Rongshou,ZHANG Siwei,WANG Ning,YANG Lei,HE Jie. An Analysis of Lung Cancer Incidence and Mortality in China,2003—2007 [J]. PRACTICAL ONCOLOGY JOURNAL, 2012, 26(1): 6-10.

Investigation and analysis of thyroid cancer incidence in Pingtan comprehensive experimental area of Fujian province,2013—2015

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments